Shanghai Huilun Life Science & Technology Co.; Ltd
发明人:
申请号：
EP17859727.4
公开号：
EP3527566A1
申请日:
2017.10.11
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to the field of pharmaceutical synthesis, and in particular to an antitumor heterocyclic imidazole compound (I), namely: a pharmaceutical salt of 4-(3-(4-(1H-imidazo[4,5-b]pyridine-5-yl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin e-1(dihydro)-ketone, a preparation method therefore, a pharmaceutical composition thereof and a use thereof in the preparation of antitumor drugs. The pharmaceutical salt of the compound (I) in the present invention may be used in the preparation of a medicament for the treatment or prevention of conditions which can be improved by inhibiting PARP activity.
